Vulvovaginal atrophy – a tale of neglect

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Climacteric

• Publication date

  2014-01-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.3109/13697137.2014.872519PMID 24423884
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Impact of vulvovaginal atrophy on sexual health and quality of life at postmenopause

  2014cited by this paper
• Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society

  2013cited by this paper
• The Vulvovaginal Symptoms Questionnaire: a questionnaire for measuring vulvovaginal symptoms in postmenopausal women

  2013cited by this paper
• Vaginal Health: Insights, Views & Attitudes (VIVA) – results from an international survey

  2012cited by this paper
• Recommendations for the management of postmenopausal vaginal atrophy

  2010cited by this paper

• Treating VVA improves symptom severity and patient-reported outcomes: 6-month PEONY results

  2025cites this paper
• Safety and efficacy of a new vaginal gel, Feminilove, for the treatment of symptoms associated with vaginal dryness and vulvovaginal atrophy in women: an in vitro and in vivo study

  2021cites this paper
• Hormone Replacement Therapy (HRT)

  2020cites this paper
• Long term absence of invasive breast cancer diagnosis in 2,402,672 pre and postmenopausal women: A systematic review and meta-analysis

  2020cites this paper
• Vaginal lubricants and moisturizers: a review into use, efficacy, and safety

  2020cites this paper
• Does age at the start of treatment for vaginal atrophy predict response to vaginal estrogen therapy? Post hoc analysis of data from a randomized clinical trial involving 205 women treated with 10 μg estradiol vaginal tablets.

  2020cites this paper
• Hormone therapy and breast cancer: risk communication and the ‘perfect storm’

  2019cites this paper
• Symptom severity and quality of life in the management of vulvovaginal atrophy in postmenopausal women.

  2019cites this paper
• Menopause and Ageing

  2018cites this paper
• The use of a plasma generator (Plexr) to treat the symptoms of vulvar and vaginal atrophy (VVA)

  2018cites this paper
• Climacteric Symptoms: Importance and Management

  2018cites this paper
• Estrogens, Selective Estrogen Receptor Modulators, and Tissue‐Selective Estrogen Complex

  2018cites this paper
• Treatment of vaginal atrophy with estriol and lactobacilli combination: a clinical review

  2018cites this paper
• Autonomy‐supportive, Web‐based lifestyle modification for cardiometabolic risk in postmenopausal women: Randomized trial

  2017cites this paper
• Treatment of Female Orgasmic Disorder

  2017cites this paper
• More evidence why the product labeling for low-dose vaginal estrogen should be changed?

  2017cites this paper
• Diagnosis and management of symptoms associated with vulvovaginal atrophy: expert opinion on behalf of the Italian VVA study group *

  2016cites this paper
• Role of Estrogens and Estrogen-Like Compounds in Female Sexual Function and Dysfunction.

  2016cites this paper
• Management of Symptoms During the Menopausal Transition

  2016cites this paper
• Novel minimally invasive laser treatment of urinary incontinence in women

  2015cites this paper
• Menopausale Hormontherapie und koronare Herzkrankheit

  2015cites this paper
• Treating vulvovaginal atrophy/genitourinary syndrome of menopause: how important is vaginal lubricant and moisturizer composition?

  2015cites this paper
• Individual fertility assessment and pro-fertility counselling; should this be offered to women and men of reproductive age?

  2015cites this paper
• Menopausal Hormone Therapy: Current Considerations.

  2015cites this paper
• Genitourinary Syndrome of Menopause in Breast Cancer Survivors: Are We Facing New and Safe Hopes?

  2015cites this paper
• Compounded bioidentical hormone therapy: identifying use trends and knowledge gaps among US women

  2015cites this paper
• Testosterone in women: can the challenges be met?

  2015cites this paper
• Impact of Functionality on Safety Risk Assessment

  2015cites this paper
• Hormone Therapy in Normal Postmenopausal Women and After Treatment for Endometrial Cancer

  2015cites this paper
• Menopausal Hormonal Therapy and Cardiovascular Disease

  2014cites this paper
• The clinical relevance of the effect of ospemifene on symptoms of vulvar and vaginal atrophy

  2014cites this paper
• The pathophysiology of menopausal symptoms

  2012cites this paper